This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexander, R. W. Articles by Dzau, V. J. Search for Related Content PubMed PubMed Citation Articles by Alexander, R. W. Articles by Dzau, V. J. Related Collections Smooth muscle proliferation and differentiation Oxidant stress Endothelium/vascular type/nitric oxide Mechanism of atherosclerosis/growth factors Other Vascular biology

(Circulation. 2000;102:IV-112.)
© 2000 American Heart Association, Inc.

Special Anniversary Issue

Vascular Biology: The Past 50 Years

R. Wayne Alexander, MD, PhD; Victor J. Dzau, MD

From the Department of Medicine, Emory University School of Medicine, Atlanta, Ga (R.W.A.), and Harvard Medical School and Department of Medicine, Brigham and Women’s Hospital, Boston, Mass (V.J.D.).

Correspondence to R. Wayne Alexander, MD, PhD, Department of Medicine, Emory University School of Medicine, Emory University Hospital, Suite H-153, 1364 Clifton Road, NE, Atlanta, GA 30322.

Key Words: vasculature • endothelium • atherosclerosis

It is an interesting endeavor to review progress in a field that did not exist 50 years ago in the present context of the term "vascular biology." Certainly, in 1950, there was basic understanding of the role of arteries and veins in cardiovascular physiology and of capillaries in gas and nutrient transport. Furthermore, there was considerable clinical knowledge about the role of atherosclerosis in ischemia and infarction of the heart and other organs and that of hypertension in inducing microvascular damage and organ failure, particularly in the kidney. "Vascular biology," which connotes the study of the biology of the constituent cells of the normal and diseased vascular wall, first gained some currency in the 1970s in defining this new field of study, which has enjoyed explosive growth in the past 25 years. Thus, the state of knowledge in 1950 must be placed in the modern context inferentially.

Vascular Biology, 1950

The vascular smooth muscle cell was appreciated for its role in controlling vascular tone in the resistance arteries. Nitroglycerin had been known for decades to relieve angina pectoris, and Osler had speculated about the role of vasospasm in precipitating ischemia and infarction. It was presumed, although not generally specifically stated, that hypercontractility of a particular coronary artery segment was being invoked, inferentially indicting the vascular smooth muscle cells. The endothelium was known to be a nonthrombogenic surface, although little was understood of the underlying molecular mechanisms. Conversely, acute cardiovascular ischemic events, such as stroke and myocardial infarction, were known to be associated frequently . . . [Full Text of this Article]

This article has been cited by other articles:

				D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., August 21, 2006; (2006) j.jacc.2006.07.008v1. [Full Text] [PDF]

				J. M. Bailey, K. A. Tanaka, and J. H. Levy Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118. [Full Text]